Invention Grant
US08367737B2 Method of using biothionol and biothionol-like compounds as anti-angiogenic agents
有权
使用生物硫醇和生物素硫醇样化合物作为抗血管生成剂的方法
- Patent Title: Method of using biothionol and biothionol-like compounds as anti-angiogenic agents
- Patent Title (中): 使用生物硫醇和生物素硫醇样化合物作为抗血管生成剂的方法
-
Application No.: US12595278Application Date: 2008-04-14
-
Publication No.: US08367737B2Publication Date: 2013-02-05
- Inventor: Zhican Qu , Anshu M. Roy , Subramaniam Ananthan
- Applicant: Zhican Qu , Anshu M. Roy , Subramaniam Ananthan
- Applicant Address: US AL Birmingham
- Assignee: Southern Research Institute
- Current Assignee: Southern Research Institute
- Current Assignee Address: US AL Birmingham
- Agency: Connolly Bove Lodge & Hutz LLP
- International Application: PCT/US2008/060186 WO 20080414
- International Announcement: WO2009/023299 WO 20090219
- Main IPC: A01N31/00
- IPC: A01N31/00 ; A61K31/10
Abstract:
The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadinc, Perphenazine, Bithionol, and Clomipramine.
Public/Granted literature
- US20100204338A1 ANTI-ANGIOGENIC AGENTS AND METHODS OF USE Public/Granted day:2010-08-12
Information query
